Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Practically Speaking: Admin Considerations for Implementing Bi-Specific Antibody

  • Broadcast in Medicine
MedOncNow

MedOncNow

×  

Follow This Show

If you liked this show, you should follow MedOncNow.
h:2444437
s:12326081
archived
Play
  • Host

To be added to the distribution list, please email: DDeCastro@southlakeregional.org

In this episode, Lorrie Reynolds takes us through the Administrative considerations for implementing Bi-Specific Antibody therapies into our practice.

Key Opinion Leader: 
Lorrie Reynolds
Director, Cancer Care Administration
Southlake Regional Cancer Centre. 

Host:
Shaqil Kassam MD. MSc. FRCPC
skassam@southlakeregional.org

Medical Oncologist
Stronach Regional Cancer Centre, Newmarket, Ontario 

Previous episodes: https://www.blogtalkradio.com/medoncnow
X @medoncnow

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled